Top Pharmaceuticals companies in Belgium by Current Liabilities

This ranking features the top 9 Pharmaceuticals companies in Belgium ranked by Current Liabilities, totalling a Current Liabilities of USD 5.15 B, for January 15, 2025.
#
Name
Current Liabilities
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 2.89 B
Dec. 31, 2023 USD 195.15 -0.39%

Belgium

2
USD 1.04 B
Dec. 31, 2023 USD 19.13 -0.63%

Belgium

3
USD 499.56 M
Dec. 31, 2023 USD 13.71 -0.44%

Belgium

4
USD 472.65 M
Dec. 31, 2023 USD 24.20 -0.41%

Belgium

5
USD 193.44 M
Dec. 31, 2023 USD 17.21 1.09%

Belgium

6
USD 21.49 M
Dec. 31, 2023 USD 2.81 6.87%

Belgium

7
USD 19.52 M
Dec. 31, 2023 USD 2.00 NA

Belgium

8
USD 15.94 M
Dec. 31, 2023 USD 9.32 -0.11%

Belgium

9
USD 7.46 M
Dec. 31, 2023 USD 6.22 -0.06%

Belgium

Frequently Asked Questions
  • Which Pharmaceuticals company in Belgium has the highest Current Liabilities ?

    The Pharmaceuticals company in Belgium with the highest Current Liabilities is UCB SA (Brussels Stock Exchange: UCB.BR) at USD 2.89 B.

  • Which Pharmaceuticals company in Belgium has the lowest Current Liabilities ?

    The Pharmaceuticals company in Belgium with the lowest Current Liabilities is Hyloris Pharmaceuticals SA (Brussels Stock Exchange: HYL.BR) at USD 7.46 M.